DEUTSCHE BANK AG\ - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 64 filers reported holding PROQR THRAPEUTICS N V in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q2 2023$624,037
-23.9%
385,2080.0%0.00%
Q1 2023$820,493
-42.4%
385,2080.0%0.00%
-100.0%
Q4 2022$1,425,270
+396.6%
385,2080.0%0.00%
Q3 2022$287,000
-4.3%
385,2080.0%0.00%
Q2 2022$300,000
-14.0%
385,2080.0%0.00%
Q1 2022$349,000
-91.4%
385,208
-24.0%
0.00%
-100.0%
Q4 2021$4,058,000
-16.5%
506,618
-12.8%
0.00%0.0%
Q3 2021$4,861,000
+24.0%
580,802
-0.1%
0.00%0.0%
Q2 2021$3,920,000
-15.9%
581,499
-17.5%
0.00%
-33.3%
Q1 2021$4,659,000
+513.0%
704,880
+289.6%
0.00%
Q4 2020$760,000
+2011.1%
180,927
+4863.7%
0.00%
Q4 2019$36,000
-83.4%
3,645
-90.4%
0.00%
Q3 2019$217,000
+36.5%
37,983
+114.4%
0.00%
Q2 2019$159,000
-45.7%
17,715
-16.7%
0.00%
Q1 2019$293,000
+113.9%
21,261
+142.3%
0.00%
Q4 2018$137,000
+197.8%
8,773
-7.7%
0.00%
Q3 2017$46,000
+411.1%
9,500
+556.5%
0.00%
Q3 2016$9,000
-87.3%
1,447
-90.3%
0.00%
Q2 2016$71,000
+688.9%
14,907
+645.4%
0.00%
Q1 2016$9,000
-93.2%
2,000
-87.0%
0.00%
Q4 2015$132,000
+388.9%
15,336
+707.2%
0.00%
Q3 2015$27,000
-93.5%
1,900
-92.4%
0.00%
Q2 2015$418,000
-17.1%
25,141
+9.0%
0.00%
Q1 2015$504,000
+105.7%
23,058
+103.7%
0.00%
Q4 2014$245,000
-41.0%
11,318
-53.1%
0.00%
Q3 2014$415,00024,1480.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders